Search results
Advancements in Biologic Therapies for Psoriatic Arthritis
Medscape· 5 days agoThe latest developments in biological therapies for psoriatic arthritis (PsA) are reviewed by Dr...
Low stress resilience is linked to increased risk of psoriasis
Medical Xpress· 5 days agoAs part of the enlistment process, all the men underwent psychological assessment in accordance with...
J&J’s Tremfya meets endpoints in Phase III ulcerative colitis trial
Clinical Trials Arena via Yahoo Finance· 5 days ago-inhibiting monoclonal antibody. It was first approved as a treatment for moderate to severe plaque...
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S. -...
Benzinga· 6 days ago"We are proud to make SIMLANDI available in the U.S. to patients and providers," said Thomas...
What To Know and Do About Jaw Pain on One Side
Health via Yahoo News· 4 hours agoCancer: Oral cancer can cause one-sided jaw pain, difficulty moving your mouth, and swelling in your jaw. Arthritis: Some forms of arthritis, including...
Alvotech (NYSE:ALVO) Releases Quarterly Earnings Results, Misses Estimates By $0.81 EPS
ETF DAILY NEWS· 2 days agoAlvotech (NYSE:ALVO – Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.89) earnings per share for the quarter, missing analysts’ consensus estimates ...
Research shows linked biological pathways driving skin inflammation
Medical Xpress· 6 days agoInflammation is the body's natural response to irritation and infection, but when out of control, it...
AbbVie (NYSE:ABBV) vs. Cosmo Pharmaceuticals (OTC:CMOPF) Head to Head Review
ETF DAILY NEWS· 2 days agoAbbVie (NYSE:ABBV – Get Free Report) and Cosmo Pharmaceuticals (OTC:CMOPF – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses ...
Maintenance Tx With Guselkumab for UC Meets All Endpoints
Medscape· 4 days agoGuselkumab (Tremfya, Janssen/Johnson & Johnson) was superior to placebo for maintenance therapy in...
Cornerstone Advisors LLC Sells 7,098 Shares of Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 5 days agoCornerstone Advisors LLC trimmed its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 5.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities ...